Literature DB >> 30407749

Shortage of energy intake rather than protein intake is associated with sarcopenia in elderly patients with type 2 diabetes: A cross-sectional study of the KAMOGAWA-DM cohort.

Takuro Okamura1, Akane Miki1, Yoshitaka Hashimoto1, Ayumi Kaji1, Ryosuke Sakai1, Takafumi Osaka1, Masahide Hamaguchi1,2, Masahiro Yamazaki1, Michiaki Fukui1.   

Abstract

BACKGROUND: Energy intake is important for the maintenance of muscle mass. The relationship between energy intake and sarcopenia in elderly patients with type 2 diabetes (T2D) has been unclear.
METHODS: Using a brief-type self-administered diet history questionnaire we assessed habitual food and nutrient intake of patients with T2D aged ≥65 years, all of whom were Japanese and physically active, taking part in the KAMOGAWA-DM cohort study. Patients' body composition was evaluated by bioimpedance analysis. Sarcopenia was defined as having both a grip strength of <26 kg for men and <18 kg for women and a skeletal muscle mass index of <7.0 kg/m2 for men and <5.7 kg/m2 for women. Logistic regression analyses were used to investigate the effect of energy intake on the presence of sarcopenia in this cross-sectional study of 391 patients (205 men, 186 women).
RESULTS: Fifty-five patients (14.1%) were diagnosed as having sarcopenia. Energy intake was significantly lower in patients with sarcopenia than without sarcopenia (mean  ±  SD [n = 366] 1498.8 ± 389.4 vs 1786.2 ± 706.7 kcal/d, respectively; P = 0.016). After adjusting for age, sex, exercise, smoking status, HbA1c, and body mass index, patients' energy intake (per 100 kcal) was negatively associated with the presence of sarcopenia (odds ratio 0.86; 95% confidence interval 0.78-0.95; P = 0.001).
CONCLUSION: Energy intake was negatively associated with the presence of sarcopenia in elderly patients with T2D.
© 2018 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  2型糖尿病; energy intake; muscle mass; nutrition; sarcopenia; type 2 diabetes; 肌肉质量; 肌萎缩; 能量摄入; 营养

Mesh:

Substances:

Year:  2018        PMID: 30407749     DOI: 10.1111/1753-0407.12874

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  22 in total

1.  URBAN-RURAL DIFFERENCES IN THE PREVALENCE OF MUSCLE WEAKNESS AND SLOW GAIT SPEED: A CROSS-SECTIONAL ANALYSIS FROM THE NHANES (2001-2002 AND 2011-2014).

Authors:  J J Aziz; K F Reid; J A Batsis; R A Fielding
Journal:  JAR Life       Date:  2021-04-07

2.  Impact of Eating Speed on Muscle Mass in Older Patients With Type 2 Diabetes: A Prospective Study of KAMOGAWA-DM Cohort.

Authors:  Genki Kobayashi; Yoshitaka Hashimoto; Fuyuko Takahashi; Ayumi Kaji; Ryosuke Sakai; Takuro Okamura; Hiroshi Okada; Noriyuki Kitagawa; Naoko Nakanishi; Saori Majima; Takafumi Osaka; Takafumi Senmaru; Emi Ushigome; Mai Asano; Masahide Hamaguchi; Masahiro Yamazaki; Michiaki Fukui
Journal:  Front Nutr       Date:  2022-06-23

Review 3.  A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors.

Authors:  Anna Izzo; Elena Massimino; Gabriele Riccardi; Giuseppe Della Pepa
Journal:  Nutrients       Date:  2021-01-09       Impact factor: 5.717

4.  Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium-glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes.

Authors:  Daisuke Yabe; Kosuke Shiki; Keiko Suzaki; Thomas Meinicke; Yutaro Kotobuki; Kenichiro Nishida; Douglas Clark; Atsutaka Yasui; Yutaka Seino
Journal:  BMJ Open       Date:  2021-04-07       Impact factor: 2.692

5.  Effect of COVID-19 Pandemic on the Change in Skeletal Muscle Mass in Older Patients with Type 2 Diabetes: A Retrospective Cohort Study.

Authors:  Yuka Hasegawa; Fuyuko Takahashi; Yoshitaka Hashimoto; Chihiro Munekawa; Yukako Hosomi; Takuro Okamura; Hiroshi Okada; Takafumi Senmaru; Naoko Nakanishi; Saori Majima; Emi Ushigome; Masahide Hamaguchi; Masahiro Yamazaki; Michiaki Fukui
Journal:  Int J Environ Res Public Health       Date:  2021-04-15       Impact factor: 3.390

6.  Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with a Low Prevalence of Sarcopenia in Patients with Type 2 Diabetes: A Cross-Sectional Study.

Authors:  Fuyuko Takahashi; Yoshitaka Hashimoto; Ayumi Kaji; Ryosuke Sakai; Yuka Kawate; Takuro Okamura; Noriyuki Kitagawa; Hiroshi Okada; Naoko Nakanishi; Saori Majima; Takafumi Senmaru; Emi Ushigome; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  Nutrients       Date:  2020-12-28       Impact factor: 5.717

7.  Let-7e-5p Regulates IGF2BP2, and Induces Muscle Atrophy.

Authors:  Takuro Okamura; Hiroshi Okada; Yoshitaka Hashimoto; Saori Majima; Takafumi Senmaru; Naoko Nakanishi; Mai Asano; Masahiro Yamazaki; Masahide Hamaguchi; Michiaki Fukui
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-24       Impact factor: 5.555

8.  Japanese radio calisthenics prevents the reduction of skeletal muscle mass volume in people with type 2 diabetes.

Authors:  Tomonori Kimura; Takuro Okamura; Keiko Iwai; Yoshitaka Hashimoto; Takafumi Senmaru; Emi Ushigome; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  BMJ Open Diabetes Res Care       Date:  2020-02

9.  Sarcopenia in Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study.

Authors:  L M Pechmann; T H Jonasson; V S Canossa; H Trierweiler; G Kisielewicz; R R Petterle; C A Moreira; V Z C Borba
Journal:  Int J Endocrinol       Date:  2020-10-29       Impact factor: 3.257

10.  Effect of Exercise Habit on Skeletal Muscle Mass Varies with Protein Intake in Elderly Patients with Type 2 Diabetes: A Retrospective Cohort Study.

Authors:  Yoshitaka Hashimoto; Ayumi Kaji; Ryosuke Sakai; Fuyuko Takahashi; Rena Kawano; Masahide Hamaguchi; Michiaki Fukui
Journal:  Nutrients       Date:  2020-10-21       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.